Himalaya Mentat DS Syrup

Himalaya Mentat DS Syrup - 100 ml

Enhances memory and learning capacity: The natural ingredients in Mentat DS improve mental quotient, memory span and concentration ability. Treats neurological disorders: Mentat DS reduces the level of tribulin, an endogenous monoamine oxidase inhibitor that is elevated during anxiety. The calming effects of Mentat DS are beneficial in treating insomnia and convulsions. As an adjuvant in neurological diseases: Due to its anticholinesterase (antispasmodic), dopaminergic-neuroprotective (important neurotransmitter in the brain), adaptogenic and antioxidant properties, Mentat DS is useful as an adjuvant in the treatment of Alzhiemer's and Parkinson's disease, epilepsy and post-stroke aphasia (speech disorder).

How to Use :
Please consult your physician to prescribe the dosage that best suits the condition. Available as syrup

Ingredients :
Indian Pennywort Madhukaparni possesses antiepileptic properties and is commonly used as an adjuvant to epileptic drugs. It balances amino acid levels, which is beneficial in treating depression. It also prevents cognitive impairment. Thyme-Leaved Gratiola Brahmi maintains cognitive function. Well known for its nootropic (memory enhancer) effect, the herb enhances memory and learning. It is also known to calm restlessness and is used to treat several mental disorders. Winter Cherry Ashvagandha is used as a mood stabilizer in clinical conditions of anxiety and depression. Withanolides, the chemical constituents present in Winter Cherry, possess rejuvenating properties. The herb also reduces oxidative stress, which can cause mental fatigue.

Indications :
Memory and learning disorders ? attention fluctuation, concentration impairment, language and learning disability Behavioral disorders ? hyperkinetic states, asocial behavior, temper tantrums, aggressive behavior, enuresis Attention deficit hyperactivity disorder (ADHD) Anxiety and stress-related disorders Mental fatigue Senile dementia As an adjuvant in Alzheimer's and Parkinson's disease Supportive therapy in mild to moderate mental retardation As an adjuvant in epilepsy and post-stroke aphasia